Currently out of the existing stock ratings of Ken Cacciatore, 91 are a BUY (68.94%), 38 are a HOLD (28.79%), 3 are a SELL (2.27%).

Ken Cacciatore

Work Performance Price Targets & Ratings Chart

Analyst Ken Cacciatore, currently employed carries an average stock price target met ratio of 35.99% that have a potential upside of 30.62% achieved within 99 days. Previously, Ken Cacciatore worked at COWEN.

Ken Cacciatore’s has documented 264 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BHVN, Biohaven Pharmaceutical Holding Co Ltd at 15-Nov-2023.

Wall Street Analyst Ken Cacciatore

Analyst best performing recommendations are on AMRN (AMARIN PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 3/30/2020. The price target of $8 was fulfilled within 1 day with a profit of $5.58 (41.09%) receiving and performance score of 410.9.

Average potential price target upside

of $15.36 (50.8%) on HZNP (HORIZON PHARMA PLC).
of $10.89 (88.39%) on ISEE (IVERIC BIO).
of $7.64 (39.96%) on BHVN (BIOHAVEN PHARMACEUTICAL HOLDING CO LTD).

ADMS Adamas Pharmaceuticals AGN Allergan plc BCRX BioCryst Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd ENDP Endo International PLC HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC TEVA Teva Pharma Industries Ltd ADR AMRN Amarin PLC ARQT Arcutis Biotherapeutics CHRS Coherus BioSciences MYL Viatris VTRS Viatris AMAG AMAG Pharmaceuticals AUPH Aurinia Pharmaceuticals RVNC Revance The EYPT Eyepoint Pharmaceuticals ISEE IVERIC bio TXMD TherapeuticsMD AERI Aerie Pharmaceuticals . BLCO Bausch + Lomb Corp BHC Bausch Health Companies OCUL Ocular Therapeutix TAK Takeda Pharmaceutical Co Ltd ADR

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Carl Byrnes (NORTHLAND CAPITAL MARKET)